Kyverna Therapeutics (KYTX) Current Assets (2022 - 2026)
Kyverna Therapeutics (KYTX) recorded Current Assets of $206.54 million in Q2 2026, down 3.6% from $214.33 million a year earlier and down 14.6% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Kyverna Therapeutics reported Current Assets of $282.95 million, down 2.6% from FY2024.
- Across earlier years, Current Assets came in at $290.6 million in FY2024 (+379.0%) and $60.66 million in FY2023.
- Quarterly Current Assets has ranged from $60.66 million in Q4 2023 to $375.49 million in Q1 2024 over the past five years.
- On a year-over-year basis, Current Assets has declined for six consecutive quarters, with growth averaging 35.9% over the last seven quarters.
- Per Business Quant, the preceding three quarters came in at $241.73 million (Q1 2026), $282.95 million (Q4 2025) and $174.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Kyverna Therapeutics | 312.78 Mn | -573.60 Mn | - | 206.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.54 Mn |
| Mar 31, 2026 | 241.73 Mn |
| Dec 31, 2025 | 282.95 Mn |
| Sep 30, 2025 | 174.93 Mn |
| Jun 30, 2025 | 214.33 Mn |
| Mar 31, 2025 | 247.65 Mn |
| Dec 31, 2024 | 290.60 Mn |
| Sep 30, 2024 | 325.37 Mn |
| Jun 30, 2024 | 348.82 Mn |
| Mar 31, 2024 | 375.49 Mn |
| Dec 31, 2023 | 60.66 Mn |
| Dec 31, 2022 | 53.25 Mn |
API Access
Kyverna Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();